Executive board
Martin Jechlinger
Group leader at the „Cell Biology and Biophysics Unit“ at the EMBL (European Molecular Biology Laboratory), Heidelberg
Martin Jechlinger studied biochemistry and neurobiology. Then he joined the group of Hartmut Beug at the IMP (Institut für Molekulare Pathologie) to study epithelial to mesenchymal transition in the context of cancer metastasis. At MSKCC in New York, later at the EMBL in Rome and now at the EMBL in Heidelberg he continued to explore breast cancer biology and the mechanisms of oncogene dependence in three-dimensional culture systems of primary mouse mammary cells.
Margrit Beug
Former teacher of Biology and Geography
Margrit Beug studied Biology and Geography in Freiburg, where she met Hartmut. She has taught biology and geography in Sindelfingen, Schriesheim and Ladenburg. In Vienna she was active in educational projects for the World Wide Fund Austria.
Board of Trustees
Anton Bauer
Scientist and Entrepreneur
Following his studies of biochemistry and immunology, Anton Bauer joined Hartmut Beug at the IMP to further understanding of cell biology and cancer mechanisms. He continued this at DKFZ (Deutsches Krebsforschungszentrum) before moving to Vienna. There, he moved from research towards translational sciences in biotech companies and start-ups (Intercell, f-star, The Antibody Lab). Most recently, he is developing a new start-up based on BESTcell stable mammalian cells.
Jacques Ghysdael
Research Director Emeritus from CNRS (National Center for Scientific Research). He investigates mechanisms in leukemogenesis at Institut Curie, Paris
After studying the genetic structure and the function of several retroviruses and their proto-oncogenic versions at the University of Southern California and the Institut Pasteur in Lille, he moved to Institut Curie, Paris. The focus of his investigations are now: the dissection of pro-oncogenic pathways involved in leukemia and of calcineurin and NFAT factors in breast cancer metastasis. During many years he had a fruitfull collaboration with Hartmut Beug
Marieke von Lindern
Head of Department of Hematopoiesis, a Research Center of Sanquin Blood Supply in Amsterdam
Marieke von Lindern obtained her PhD degree in the Dept. Cell Biology and Genetics at the Erasmus University, Rotterdam. Then she worked at the IMP in Vienna, being trained by Hartmut Beug in the cell biology of erythropoesis. At the Department of Hematology at the Erasmus Center and at the Research Center of Sanquin Blood Supply she continues studying molecular mechanisms in erythropoiesis.